Wolfgang Abenhardt
Gilching, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Results of a Prospective Non-Interventional Post-Authorization Safety Study of Idelalisib in Germany.
Journal: Clinical lymphoma, myeloma & leukemia
Published: March 01, 2022
Rare lymphomas in routine practice - Treatment and outcome in marginal zone lymphoma in the prospective German Tumour Registry Lymphatic Neoplasms.
Journal: Hematological oncology
Published: February 17, 2021
Buparlisib in combination with tamoxifen in pretreated patients with hormone receptor-positive, HER2-negative advanced breast cancer molecularly stratified for PIK3CA mutations and loss of PTEN expression.
Journal: Cancer medicine
Published: February 10, 2020
Rare lymphomas in routine practice-Treatment and outcome in Waldenström's macroglobulinaemia in the prospective German Tumour Registry Lymphatic Neoplasms.
Journal: Hematological oncology
Published: November 25, 2019
Similar effectiveness of R-CHOP-14 and -21 in diffuse large B-cell lymphoma-data from the prospective German Tumour Registry Lymphatic Neoplasms.
Journal: European journal of haematology
Published: April 15, 2019
Prognostic model for newly diagnosed CLL patients in Binet stage A: results of the multicenter, prospective CLL1 trial of the German CLL study group.
Journal: Leukemia
Published: January 05, 2019
Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry.
Journal: Cancers
Published: October 28, 2018
Early, risk-adapted treatment with fludarabine in Binet stage A chronic lymphocytic leukemia patients: results of the CLL1 trial of the German CLL study group.
Journal: Leukemia
Published: August 15, 2017
Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors - Data from the German PRAEGNANT breast cancer registry.
Journal: Breast (Edinburgh, Scotland)
Published: April 29, 2017
Preference of elderly patients' to oral or intravenous chemotherapy in heavily pre-treated recurrent ovarian cancer: final results of a prospective multicenter trial.
Journal: Gynecologic oncology research and practice
Published: November 24, 2016
Alemtuzumab consolidation in chronic lymphocytic leukaemia: a phase I/II multicentre trial.
Journal: European journal of haematology
Published: November 02, 2016
Re-irradiation strategies in combination with bevacizumab for recurrent malignant glioma.
Journal: Journal of neuro-oncology
Published: July 26, 2016
Last Updated: 09/26/2026